Dextromethorphan
OtherSexual Well-Being
In plain English
Dextromethorphan is the cough suppressant found in many over-the-counter cold medicines. Beyond cough, it acts on brain receptors and is being used in prescription combinations for conditions like pseudobulbar affect and depression. At normal doses it is safe for short-term cough; at high 'recreational' doses it can cause dangerous dissociative and serotonergic effects, and it can interact with antidepressants.
The science
Dextromethorphan is an NMDA-receptor antagonist and sigma-1 agonist that also weakly inhibits serotonin/norepinephrine reuptake; the theoretical rationale for premature-ejaculation combinations is that NMDA antagonism may modulate the ejaculatory reflex. However, human evidence specifically supporting dextromethorphan for premature ejaculation is lacking—there are no published randomized controlled trials of dextromethorphan for this indication, and its appearance in this space derives largely from patent/combination concepts rather than clinical efficacy data. By contrast, the evidence-based pharmacotherapies for premature ejaculation are SSRIs/dapoxetine and, with more caution, tramadol and topical anesthetics. Dextromethorphan carries risks of serotonergic interactions (serotonin syndrome with MAOIs/SSRIs), dissociative effects and abuse at high doses, and dizziness/somnolence. Its use here is off-label and unproven; combination capsules are not FDA-approved formulations.
References
- Pryor et al., Lancet 2006 (dapoxetine PE trials — the evidence-based comparator)
- Martyn-St James et al., BMC Urol 2015 (PE pharmacotherapy evidence context)
- Journey JD et al., Dextromethorphan, StatPearls (NCBI Bookshelf) 2024
- Journey JD & Bentley TP, Dextromethorphan Toxicity, StatPearls (NCBI Bookshelf) 2023